142 related articles for article (PubMed ID: 26458676)
1. Late relapse of testicular cancer: Recurrence after 24 years and treatment with chemotherapy alone.
Akar E; Tural D; Arslan D; Başsorgun Cİ; Yıldız Ö
J Cancer Res Ther; 2015; 11(3):661. PubMed ID: 26458676
[TBL] [Abstract][Full Text] [Related]
2. One cycle of bleomycin, etoposide and cisplatin plus two cycles of etopeside and cisplatin chemotherapy in selected patients with low-volume stage II nonseminomatous germ cell tumor of the testis.
Mezvrishvili Z; Managadze L
Urol Int; 2005; 75(4):304-8. PubMed ID: 16327295
[TBL] [Abstract][Full Text] [Related]
3. Late relapse of nonseminomatous germ cell tumor of the testis: successful treatment with salvage chemotherapy alone.
Papadimitris C; Papadimitriou C; Kokolakis N; Athanassiades P; Dimopoulos MA
Urology; 1997 Mar; 49(3):469-70. PubMed ID: 9123720
[TBL] [Abstract][Full Text] [Related]
4. Selected use of aggressive adjuvant chemotherapy in resected stage II nonseminomatous germ cell tumors of the testis.
Pizzocaro G
Prog Clin Biol Res; 1985; 203():585-90. PubMed ID: 2421344
[No Abstract] [Full Text] [Related]
5. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
6. [Testis germ cell tumours: which chemotherapy, for which patients?].
Fléchon A; Droz JP
Ann Urol (Paris); 2007 Apr; 41(2):56-67. PubMed ID: 17486913
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
[TBL] [Abstract][Full Text] [Related]
8. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M;
J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040
[TBL] [Abstract][Full Text] [Related]
9. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
10. The impact of bleomycin on retroperitoneal histology at post-chemotherapy retroperitoneal lymph node dissection of good risk germ cell tumors.
Cary KC; Pedrosa JA; Kaimakliotis HZ; Masterson TA; Einhorn LH; Foster RS
J Urol; 2015 Feb; 193(2):507-12. PubMed ID: 25254937
[TBL] [Abstract][Full Text] [Related]
11. Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy.
Kondagunta GV; Sheinfeld J; Mazumdar M; Mariani TV; Bajorin D; Bacik J; Bosl GJ; Motzer RJ
J Clin Oncol; 2004 Feb; 22(3):464-7. PubMed ID: 14752068
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
13. Etoposide and cisplatin with or without bleomycin as first-line chemotherapy for patients with small-volume metastases of testicular nonseminoma.
Peckham MJ; Horwich A; Blackmore C; Hendry WF
Cancer Treat Rep; 1985 May; 69(5):483-8. PubMed ID: 2408750
[TBL] [Abstract][Full Text] [Related]
14. Ifosfamide in testicular cancer: the Indiana University experience.
Loehrer PJ; Williams SD; Einhorn LH
Semin Oncol; 1989 Feb; 16(1 Suppl 3):96-101. PubMed ID: 2539649
[TBL] [Abstract][Full Text] [Related]
15. Testicular germ cell tumors in adolescents - results of the protocol MAHO 98 and the identification of good risk patients.
Göbel U; Calaminus G; Haas R; Teske C; Schönberger S; Schneider DT; Leuschner I; Harms D
Klin Padiatr; 2014 Nov; 226(6-7):316-22. PubMed ID: 25431864
[TBL] [Abstract][Full Text] [Related]
16. Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: the SWENOTECA management program.
Tandstad T; Dahl O; Cohn-Cedermark G; Cavallin-Stahl E; Stierner U; Solberg A; Langberg C; Bremnes RM; Laurell A; Wijkstrøm H; Klepp O
J Clin Oncol; 2009 May; 27(13):2122-8. PubMed ID: 19307506
[TBL] [Abstract][Full Text] [Related]
17. Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group.
Olofsson SE; Tandstad T; Jerkeman M; Dahl O; Ståhl O; Klepp O; Bremnes RM; Cohn-Cedermark G; Langberg CW; Laurell A; Solberg A; Stierner U; Wahlqvist R; Wijkström H; Anderson H; Cavallin-Ståhl E
J Clin Oncol; 2011 May; 29(15):2032-9. PubMed ID: 21482994
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study.
Tandstad T; Cohn-Cedermark G; Dahl O; Stierner U; Cavallin-Stahl E; Bremnes RM; Klepp O
Ann Oncol; 2010 Sep; 21(9):1858-1863. PubMed ID: 20142410
[TBL] [Abstract][Full Text] [Related]
19. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy and follow-up for recurrences in localized testicular cancer.
Boulos S; Mazhar D; Warren AY; Wong HH
Future Oncol; 2017 May; 13(11):947-950. PubMed ID: 28481147
[No Abstract] [Full Text] [Related]
[Next] [New Search]
